Therapeutic targets to overcome glioblastoma radioresistance (IMAGE)
Caption
Researchers from Korea and USA unveil the mechanism of radioresistance, or resistance to chemotherapy, in glioblastoma (brain cancer) cells, identifying potential therapeutic targets and a clinical drug, cladribine, that could potentially revolutionize the current treatment strategy for glioblastoma.
Credit
BuHyun Youn from Pusan National University, Korea
Usage Restrictions
Cannot be reused without permission.
License
Original content